NANO-X IMAGING (NNOX)
Nasdaq Markedet er stengt
Nano-X Imaging Ltd is a medical imaging technology company that seeks to broaden access to diagnostic imaging and support earlier detection of disease. The company’s platform combines imaging hardware, cloud-based infrastructure, artificial intelligence tools, radiology services, and healthcare information technology, positioning it at the intersection of medical devices, software, and outsourced clinical services.
Its best-known hardware initiative is the Nanox.ARC, an imaging system designed as a more accessible alternative to conventional medical imaging equipment. The broader Nanox model is not limited to the scanner itself. The company also develops software intended to connect imaging sites, radiologists, and healthcare providers, while its AI tools are designed to assist with the analysis of medical images and help identify conditions that may require clinical follow-up.
Nano-X Imaging reports its activities through three main areas: the Nanox.ARC segment, the AI and software solutions segment, and the radiology services segment. The radiology services business is an important revenue contributor, reflecting the company’s role in supporting image interpretation and related workflow services for healthcare providers. This gives Nano-X exposure not only to future adoption of its own imaging hardware, but also to ongoing demand for outsourced radiology capacity.
For investors, NNOX is a healthcare technology stock tied to the long-term themes of preventive care, imaging accessibility, artificial intelligence in diagnostics, and cloud-enabled clinical workflows. Its investment case depends on regulatory progress, commercial deployment, adoption by healthcare systems, and the company’s ability to prove that its integrated platform can deliver reliable imaging, efficient interpretation, and economically attractive services at scale.
Sist oppdatert
- Markedsverdi
- —
- P/E-tall
- —
- P/FCF-tall
- —
- P/S-tall
- —
- Selskapsverdi
- —
- Sektor
- —
- Bransje
- —
- Adresse
- —
NNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX
NNOX SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
NNOX Investors Have Opportunity to Join Nano-X Imaging Ltd. Fraud Investigation with the Schall Law Firm
NANO-X INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Nano-X Imaging Ltd. on Behalf of Nano-X Stockholders and Encourages Investors to Contact the Firm
Nanox Announces $15 Million Registered Direct Offering of Common Stock
Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging
Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication
Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography
Are Business Services Stocks Lagging NanoX Imaging (NNOX) This Year?
Down -19.76% in 4 Weeks, Here's Why NanoX Imaging (NNOX) Looks Ripe for a Turnaround
Bears are Losing Control Over NanoX Imaging (NNOX), Here's Why It's a 'Buy' Now
Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
Nanox Files 2023 Annual Report on Form 20-F
Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases
All Eyes on Nvidia Earnings: Here's What to Expect
Resultatregnskap
| Post | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Omsetning | — | — | — | — | — |
| Bruttofortjeneste | — | — | — | — | — |
| Driftsresultat | — | — | — | — | — |
| Driftsresultat før avskrivninger (EBITDA) | 0 | 0 | 0 | 0 | 0 |
| Nettoresultat | — | — | — | — | — |
| Grunnleggende EPS | — | — | — | — | — |
| Utvanet EPS | — | — | — | — | — |
Balanse
| Post | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Sum eiendeler | 162.17M | 210M | 218.65M | 253.93M | 363.17M |
| Sum gjeld | 22.43M | 20.88M | 23.13M | 37.25M | 71.02M |
| Egenkapital | 139.73M | 189.12M | 195.51M | 216.68M | 292.15M |
| Kontanter og ekvivalenter | 49.15M | 39.3M | 56.38M | 38.46M | 66.65M |
| Omløpsmidler | 66.79M | 78.68M | 88.59M | 82.46M | 94.86M |
| Kortsiktig gjeld | 16.89M | 13.97M | 15.52M | 25.07M | 52.75M |
Kontantstrøm
| Post | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Kontantstrøm fra drift | — | — | — | — | — |
| Kontantstrøm fra investeringer | — | — | — | — | — |
| Kontantstrøm fra finansiering | — | — | — | — | — |
| Endring i kontanter | — | — | — | — | — |
| Type | Rapport | Dato | Lenke |
|---|---|---|---|
| edgar index | SCHEDULE 13G/A — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 6-K — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| form 3 | Form 3 — Yahav Attias Gali | Vis rapport | |
| form 3 | Form 3 — Yahav Attias Gali | Vis rapport | |
| form 3 | Form 3 — Yahav Attias Gali | Vis rapport | |
| form 3 | Form 3 — Yahav Attias Gali | Vis rapport | |
| form 3 | Form 3 — Yahav Attias Gali | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| form 3 | Form 3 — Alroy Erez | Vis rapport | |
| form 3 | Form 3 — Alroy Erez | Vis rapport | |
| form 3 | Form 3 — Alroy Erez | Vis rapport | |
| form 3 | Form 3 — Alroy Erez | Vis rapport | |
| form 3 | Form 3 — saban sharon | Vis rapport | |
| form 3 | Form 3 — saban sharon | Vis rapport | |
| edgar index | CORRESP — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | F-3/A — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 4 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| form 3 | Form 3 — Ronen Nehama | Vis rapport | |
| form 3 | Form 3 — Ronen Nehama | Vis rapport | |
| form 3 | Form 3 — Ronen Nehama | Vis rapport | |
| edgar index | UPLOAD — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| form 3 | Form 3 — Kainan Noga | Vis rapport | |
| form 3 | Form 3 — Kainan Noga | Vis rapport | |
| form 3 | Form 3 — Kainan Noga | Vis rapport | |
| form 3 | Form 3 — Kainan Noga | Vis rapport | |
| form 3 | Form 3 — Kainan Noga | Vis rapport | |
| form 3 | Form 3 — Kainan Noga | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 3 — Nano-X Imaging Ltd. | Vis rapport | |
| form 3 | Form 3 — Aharon Cohen Tamar | Vis rapport | |
| form 3 | Form 3 — Aharon Cohen Tamar | Vis rapport | |
| form 3 | Form 3 — Aharon Cohen Tamar | Vis rapport | |
| form 3 | Form 3 — Aharon Cohen Tamar | Vis rapport | |
| form 3 | Form 3 — Aharon Cohen Tamar | Vis rapport | |
| form 3 | Form 3 — Aharon Cohen Tamar | Vis rapport | |
| form 3 | Form 3 — Koren Ofir | Vis rapport | |
| form 3 | Form 3 — Koren Ofir | Vis rapport | |
| form 3 | Form 3 — Koren Ofir | Vis rapport | |
| form 3 | Form 3 — Koren Ofir | Vis rapport | |
| form 3 | Form 3 — Koren Ofir | Vis rapport | |
| form 3 | Form 3 — Koren Ofir | Vis rapport | |
| form 3 | Form 3 — Jackman Michael | Vis rapport | |
| form 3 | Form 3 — Jackman Michael | Vis rapport | |
| form 3 | Form 3 — Jackman Michael | Vis rapport | |
| form 3 | Form 3 — Gofman Feler Marina | Vis rapport | |
| form 3 | Form 3 — Gofman Feler Marina | Vis rapport | |
| form 3 | Form 3 — Gofman Feler Marina | Vis rapport | |
| form 3 | Form 3 — Gofman Feler Marina | Vis rapport | |
| form 3 | Form 3 — Gofman Feler Marina | Vis rapport | |
| form 3 | Form 3 — Dara James | Vis rapport | |
| form 3 | Form 3 — Dara James | Vis rapport | |
| form 3 | Form 3 — Dara James | Vis rapport | |
| form 3 | Form 3 — Dara James | Vis rapport | |
| form 3 | Form 3 — Dara James | Vis rapport | |
| form 3 | Form 3 — Meltzer Erez | Vis rapport | |
| form 3 | Form 3 — Meltzer Erez | Vis rapport | |
| form 3 | Form 3 — Meltzer Erez | Vis rapport | |
| form 3 | Form 3 — Meltzer Erez | Vis rapport | |
| form 4 | Form 4 — Daniel Ran | Vis rapport | |
| edgar index | F-3 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 6-K — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 6-K — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 6-K — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 6-K — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 424B5 — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 6-K — Nano-X Imaging Ltd. | Vis rapport | |
| edgar index | 6-K — Nano-X Imaging Ltd. | Vis rapport |